Terms: = Kidney tumors AND JAK2, ENSG00000096968, O60674, JTK10, 3717
63 results:
1. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic jak2/STAT3 signaling: In vitro and in vivo therapeutic intervention.
He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
[TBL] [Abstract] [Full Text] [Related]
2. The association between hepatic viral infections and cancers: a cross-sectional study in the Taiwan adult population.
Maliko M; Su FH; Kamiza AB; Su MJ; Yeh CC
Clin Exp Med; 2024 Jan; 24(1):20. PubMed ID: 38279980
[TBL] [Abstract] [Full Text] [Related]
3. Enhanced synergy of pacritinib with temsirolimus and sunitinib in preclinical renal cell carcinoma model by targeting jak2/STAT pathway.
Mao F; Gao L; Liu L; Tang Y
J Chemother; 2024 May; 36(3):238-248. PubMed ID: 37916436
[TBL] [Abstract] [Full Text] [Related]
4. Tumor Mutational Burden Testing in Solid tumors.
Kwon R; Cheng HH; Pritchard CC
JAMA Oncol; 2023 Dec; 9(12):1725-1726. PubMed ID: 37883072
[TBL] [Abstract] [Full Text] [Related]
5. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-jak2-STAT1 pathway.
Du L; Wang B; Wu M; Chen W; Wang W; Diao W; Ding M; Chen W; Cao W; Guo H; Zhang G
Cancer Lett; 2023 Dec; 578():216463. PubMed ID: 37866544
[TBL] [Abstract] [Full Text] [Related]
6. KIF2C promotes clear cell renal cell carcinoma progression via activating jak2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract] [Full Text] [Related]
7. Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives.
Krecak I; Verstovsek S; Lucijanic M
Ann Hematol; 2024 May; 103(5):1513-1523. PubMed ID: 37665349
[TBL] [Abstract] [Full Text] [Related]
8. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
[TBL] [Abstract] [Full Text] [Related]
9. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating jak2/STAT3 Pathway.
Zhu WT; Zeng XF; Yang H; Jia ML; Zhang W; Liu W; Liu SY
Int J Nanomedicine; 2023; 18():2677-2691. PubMed ID: 37228445
[TBL] [Abstract] [Full Text] [Related]
10. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Verstovsek S; Gerds AT; Vannucchi AM; Al-Ali HK; Lavie D; Kuykendall AT; Grosicki S; Iurlo A; Goh YT; Lazaroiu MC; Egyed M; Fox ML; McLornan D; Perkins A; Yoon SS; Gupta V; Kiladjian JJ; Granacher N; Lee SE; Ocroteala L; Passamonti F; Harrison CN; Klencke BJ; Ro S; Donahue R; Kawashima J; Mesa R;
Lancet; 2023 Jan; 401(10373):269-280. PubMed ID: 36709073
[TBL] [Abstract] [Full Text] [Related]
11. Energy-Stress-Mediated AMPK Activation Promotes GPX4-Dependent Ferroptosis through the jak2/STAT3/P53 Axis in Renal Cancer.
Li Y; Zhang Y; Qiu Q; Wang L; Mao H; Hu J; Chen Z; Du Y; Liu X
Oxid Med Cell Longev; 2022; 2022():2353115. PubMed ID: 36246395
[TBL] [Abstract] [Full Text] [Related]
12. Heterogeneity of Platelet Derived Growth Factor Pathway Gene Expression Profile Defines Three Distinct Subgroups of Renal Cell Carcinomas.
Ferician AM; Ferician OC; Cumpanas AD; Berzava PL; Nesiu A; Barmayoun A; Cimpean AM
Cancer Genomics Proteomics; 2022; 19(4):477-489. PubMed ID: 35732321
[TBL] [Abstract] [Full Text] [Related]
13. Anlotinib combined with the PD-L1 blockade exerts the potent anti-tumor immunity in renal cancer treatment.
Li J; Cao P; Chen Y; Wang J; Sun X; Chen R; Wang G; Hou J
Exp Cell Res; 2022 Aug; 417(1):113197. PubMed ID: 35568074
[TBL] [Abstract] [Full Text] [Related]
14. Dissection of PD-L1 promoter reveals differential transcriptional regulation of PD-L1 in VHL mutant clear cell renal cell carcinoma.
Kong SK; Kim BS; Lim H; Kim HJ; Kim YS
Lab Invest; 2022 Apr; 102(4):352-362. PubMed ID: 34789838
[TBL] [Abstract] [Full Text] [Related]
15. Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.
Dawoud AAZ; Gilbert RD; Tapper WJ; Cross NCP
Leukemia; 2022 Feb; 36(2):507-515. PubMed ID: 34413458
[TBL] [Abstract] [Full Text] [Related]
16. Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened kidney Function.
Kwiatkowski J; Kuliszkiewicz-Janus M; Rymer W; Jaźwiec B; Małecki R
Pharmacology; 2021; 106(5-6):316-322. PubMed ID: 33691325
[TBL] [Abstract] [Full Text] [Related]
17. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
Liu H; Li X; Duan Y; Xie JB; Piao XL
J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
[TBL] [Abstract] [Full Text] [Related]
18. Nobiletin inhibits viability of human renal carcinoma cells via the jak2/STAT3 and PI3K/Akt pathway.
Xu Z; Wu D; Fu D; Tang C; Ge J; Zhang Z; Zhou W
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):199-203. PubMed ID: 33040836
[TBL] [Abstract] [Full Text] [Related]
19. Sclerosing Extramedullary Hematopoietic Tumor: A Case Report.
Wang D; Castro E; Rao A; McPhaul CM
J Investig Med High Impact Case Rep; 2020; 8():2324709620956463. PubMed ID: 32911987
[TBL] [Abstract] [Full Text] [Related]
20. A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma.
Perumal K; Mun KS; Yap NY; Razack AHA; Gobe GC; Ong TA; Kuppusamy S; Rajandram R
Biomed Res Int; 2020; 2020():3682086. PubMed ID: 32802842
[TBL] [Abstract] [Full Text] [Related]
[Next]
